Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y, Fujita T, Nakahara K, Fukumoto S, Yamashita T (2004) FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 19:429–435
Article CAS PubMed Google Scholar
Hidaka N, Koga M, Kimura S, Hoshino Y, Kato H, Kinoshita Y, Makita N, Nangaku M, Horiguchi K, Furukawa Y, Ohnaka K, Inagaki K, Nakagawa A, Suzuki A, Takeuchi Y, Fukumoto S, Nakatani F, Ito N (2022) Clinical challenges in diagnosis, tumor localization and treatment of tumor-induced osteomalacia: outcome of a retrospective surveillance. J Bone Miner Res 37:1479–1488
Article CAS PubMed Google Scholar
Kato H, Koga M, Kinoshita Y, Hidaka N, Hoshino Y, Takashi Y, Arai M, Kobayashi H, Katsura M, Nakamoto Y, Makise N, Ushiku T, Hoshi K, Nangaku M, Makita N, Fukumoto S, Ito N (2022) Utility of multimodality approach including systemic FGF23 venous sampling in localizing phosphaturic mesenchymal tumors. J Endocr Soc 7:bvac181
Article PubMed PubMed Central Google Scholar
Chong WH, Andreopoulou P, Chen CC, Reynolds J, Guthrie L, Kelly M, Gafni RI, Bhattacharyya N, Boyce AM, El-Maouche D, Crespo DO, Sherry R, Chang R, Wodajo FM, Kletter GB, Dwyer A, Collins MT (2013) Tumor localization and biochemical response to cure in tumor-induced osteomalacia. J Bone Miner Res 28:1386–1398
Article CAS PubMed PubMed Central Google Scholar
Jiang Y, Hou G, Cheng W (2020) Performance of 68Ga-DOTA-SST PET/CT, octreoscan SPECT/CT and 18F-FDG PET/CT in the detection of culprit tumors causing osteomalacia: a meta-analysis. Nucl Med Commun 41:370–376
Article CAS PubMed PubMed Central Google Scholar
El-Maouche D, Sadowski SM, Papadakis GZ, Guthrie L, Cottle-Delisle C, Merkel R, Millo C, Chen CC, Kebebew E, Collins MT (2016) (68)Ga-DOTATATE for tumor localization in tumor-induced osteomalacia. J Clin Endocrinol Metab 101:3575–3581
Article CAS PubMed PubMed Central Google Scholar
Hoshino Y, Okamoto K, Ogawa T, Kato H, Irie K, Watanabe S, Kimura S, Hidaka N, Kinoshita Y, Kobayashi H, Hagiwara D, Kogawa M, Takayanagi H, Tanaka S, Nangaku M, Makita N, Burbelo PD, Saito T, Ito N (2025) Acquired osteomalacia associated with autoantibodies against PHEX. N Engl J Med 392:513–515
Article PubMed PubMed Central Google Scholar
Hartley IRIS, Roszko KL, Gafni RI, Futran J, Galisteo R, Bonilla FT, Samuel K, Burbelo P, Ferreira CR (2025) (SUN-572) PHEX Autoantibodies in idiopathic FGF23-mediated hypophosphatemia. Seattle, Washington
Shimazaki S, Kazukawa I, Yamammoto H, Mori K, Kihara M, Naruke Y, Minagawa M (2022) Elevation of serum fibroblast growth factor 23 level in a pediatric patient with lupus nephritis. CEN Case Rep 11:50–54
Kawaguchi T, Inamo Y (2023) Inappropriate secretion of fibroblast growth factor 23 despite hypophosphataemia with changes in bone turnover markers in a girl with systemic lupus erythematosus: case report and review of the literature. Mod Rheumatol Case Rep 7:60–64
Tabei Y, Ohtsu Y, Shimada M, Wada A, Hamajima E, Osawa Y, Takizawa T (2024) FGF23-related hypophosphatemic rickets preceding the onset of systemic lupus erythematosus: a juvenile case. Clin Case Rep 12:e8420
Article PubMed PubMed Central Google Scholar
Parkes M, Cortes A, van Heel DA, Brown MA (2013) Genetic insights into common pathways and complex relationships among immune-mediated diseases. Nat Rev Genet 14:661–673
Article CAS PubMed Google Scholar
Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR (2010) A method and server for predicting damaging missense mutations. Nat Methods 7:248–249
Article CAS PubMed PubMed Central Google Scholar
Sim NL, Kumar P, Hu J, Henikoff S, Schneider G, Ng PC (2012) SIFT web server: predicting effects of amino acid substitutions on proteins. Nucleic Acids Res 40:W452-457
Article CAS PubMed PubMed Central Google Scholar
Nagamine K, Peterson P, Scott HS, Kudoh J, Minoshima S, Heino M, Krohn KJ, Lalioti MD, Mullis PE, Antonarakis SE, Kawasaki K, Asakawa S, Ito F, Shimizu N (1997) Positional cloning of the APECED gene. Nat Genet 17:393–398
Article CAS PubMed Google Scholar
Anderson MS, Venanzi ES, Klein L, Chen Z, Berzins SP, Turley SJ, von Boehmer H, Bronson R, Dierich A, Benoist C, Mathis D (2002) Projection of an immunological self shadow within the thymus by the aire protein. Science 298:1395–1401
Article CAS PubMed Google Scholar
Mathis D, Benoist C (2007) A decade of AIRE. Nat Rev Immunol 7:645–650
Article CAS PubMed Google Scholar
Bez P, Ceraudo M, Vianello F, Rattazzi M, Scarpa R (2024) Where AIRE we now? Where AIRE we going? Curr Opin Allergy Clin Immunol 24:448–456
Article PubMed PubMed Central Google Scholar
Cui X, Liu W, Jiang H, Zhao Q, Hu Y, Tang X, Liu X, Dai H, Rui H, Liu B (2025) IL-12 family cytokines and autoimmune diseases: a potential therapeutic target? J Transl Autoimmun 10:100263
Article CAS PubMed Google Scholar
Fierabracci A, Milillo A, Locatelli F, Fruci D (2012) The putative role of endoplasmic reticulum aminopeptidases in autoimmunity: insights from genomic-wide association studies. Autoimmun Rev 12:281–288
Article CAS PubMed Google Scholar
Das T, Chen Z, Hendriks RW, Kool M (2018) A20/tumor necrosis factor α-induced protein 3 in immune cells controls development of autoinflammation and autoimmunity: lessons from mouse models. Front Immunol 9:104
Article PubMed PubMed Central Google Scholar
Stanford SM, Bottini N (2014) PTPN22: the archetypal non-HLA autoimmunity gene. Nat Rev Rheumatol 10:602–611
Article CAS PubMed PubMed Central Google Scholar
Trombetti A, Al-Daghri N, Brandi ML, Cannata-Andía JB, Cavalier E, Chandran M, Chaussain C, Cipullo L, Cooper C, Haffner D, Harvengt P (2022) Interdisciplinary management of FGF23-related phosphate wasting syndromes: a consensus statement on the evaluation, diagnosis and care of patients with X-linked hypophosphataemia. Nat Rev Endocrinol 18:366–384
Kato H, Koga M, Kinoshita Y, Taniguchi Y, Kobayashi H, Fukumoto S, Nangaku M, Makita N, Ito N (2021) Incidence of complications in 25 adult patients with X-linked hypophosphatemia. J Clin Endocrinol Metab 106:e3682–e3692
Beck-Nielsen SS, Brusgaard K, Rasmussen LM, Brixen K, Brock-Jacobsen B, Poulsen MR, Vestergaard P, Ralston SH, Albagha OM, Poulsen S, Haubek D, Gjørup H, Hintze H, Andersen MG, Heickendorff L, Hjelmborg J, Gram J (2010) Phenotype presentation of hypophosphatemic rickets in adults. Calcif Tissue Int 87:108–119
Article CAS PubMed Google Scholar
Kato H, Okawa R, Ogasawara T, Hoshino Y, Hidaka N, Koga M, Kinoshita Y, Kobayashi H, Taniguchi Y, Fukumoto S, Nangaku M, Makita N, Hoshi K, Nakano K, Ito N (2023) Effect of conventional treatment on dental complications and ectopic ossifications among 30 adults with XLH. J Clin Endocrinol Metab 108:1405–1414
Insogna KL, Briot K, Imel EA, Kamenický P, Ruppe MD, Portale AA, Weber T (2018) A randomized, double-blind, placebo-controlled, phase 3 trial evaluating the efficacy of burosumab, an anti-FGF23 antibody, in adults with X-linked hypophosphatemia: week 24 primary analysis. J Bone Miner Res 33:1383–1393
Comments (0)